Avid Bioservices Inc CDMO

NAS: CDMO | ISIN: US05368M1062 14/11/2024

11,93 USD (-2,21%)

(-2,21%) 14/11/2024

Grafiek Avid Bioservices Inc

Grafiek Avid Bioservices Inc

1 dag1d -2,21%
1 week1w -2,69%
1 maand1m 16,16%
3 maanden3m 11,70%
6 maanden6m 28,97%
1 jaar1j 127,24%
5 jaar5j 128,11%

Avid Bioservices Inc in het nieuws

Toon enkel gratis nieuws

2 december 2023 · Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 · Persbericht

16 juni 2022 · Avid Bioservices, Inc. and CRB highlight efforts that enabled opening of first phase of new viral vector facility in California in only eight months · Persbericht

26 oktober 2021 · Avid Bioservices Set to Join S&P SmallCap 600 · Persbericht

17 maart 2021 · Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum · Persbericht

10 maart 2021 · Avid Bioservices, Inc. Announces Pricing of $125 Million Offering of Exchangeable Senior Notes · Persbericht

8 maart 2021 · Avid Bioservices, Inc. Announces Proposed $125 Million Offering of Exchangeable Senior Notes · Persbericht

8 maart 2021 · Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2021 and Recent Developments · Persbericht

3 maart 2021 · Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock · Persbericht

1 maart 2021 · Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2021 After Market Close on March 8, 2021 · Persbericht

22 februari 2021 · Avid Bioservices Begins Phase 2 of its Myford Manufacturing Capacity Expansion Plan · Persbericht

Profiel Avid Bioservices Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Medische Specialiteiten

CEO: Nicholas Green

Werknemers: 307

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe